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Abstract
Fluorescent proteins are powerful markers allowing tracking expression, intracellular
localization, and translocation of tagged proteins but their effects on the structure and assembly
of complex extracellular matrix proteins has not been investigated. Here, we analyzed the utility
of fluorescent proteins as markers for procollagen VII, a triple-helical protein critical for the
integrity of dermal-epidermal junction. DNA constructs encoding a red fluorescent proteintagged wild type mini-procollagen VII α chain and green fluorescent protein-tagged α chains
harboring selected mutations were genetically engineered. These DNA constructs were coexpressed in HEK-293 cells and the assembly of heterogeneous triple-helical mini-procollagen
VII molecules was analyzed. Immunoprecipitation and fluorescence resonance energy transfer
assays demonstrated that the presence of different fluorescent protein markers at the C-termini of
individual α chains neither altered formation of triple-helical molecules nor affected their
secretion to the extracellular space. Our study provides a basis for employing fluorescent
proteins as tags for complex structural proteins of extracellular matrix.

Keywords: fluorescent proteins, collagen VII, collagen mutations, FRET, extracellular matrix.
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Introduction
Fluorescent proteins derived from marine organisms have become a powerful tool for
studies in a number of biological research areas (for review see [1; 2]). A classical application of
such proteins is to use them as intracellular markers fused with proteins of interest. In addition to
the native fluorescent proteins, their genetically modified versions were also engineered. These
modified variants with optimized fluorescence characteristics and reduced ability to selfaggregate allow determining the expression of the protein of interest, their subcellular
localization and translocation, and enable detecting their interactions with other macromolecules
[1; 2].
One of the limits of fusing fluorescent proteins with proteins of interest is the concern
that their presence could alter the folding of these tagged proteins, thereby inhibiting their natural
functions. This concern is particularly relevant to proteins consisting of subunits whose assembly
into functional oligomers could be altered by the presence of fluorescent tags. A number of
structural proteins found in extracellular matrices of various connective tissues are characterized
by the oligomeric structure. A group of such complex proteins includes various collagens,
matrilins, laminins, and fibronectin, to name a few.
A common characteristic of different collagen types is that they are formed by
intracellular co-assembly of three homotypic or heterotypic polypeptide subunits [3]. It has been
demonstrated that such co-assembly is a complex process which depends on the precise
alignment of individual chains through a mechanism controlled by site-specific interactions of
particular domains [4; 5].
Because of the stringent requirement for alignment of individual collagen α chains,
tagging them with bulky fluorescent proteins presents a potential problem. The presence of these
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proteins at either terminus of collagen chains could not only alter the formation of the collagen
triple helix, but also could prevent secretion of collagen-fluorescent protein chimeras from cells.
In a number of collagen-related studies fluorescent proteins were employed as reporters for
monitoring the activity of specific promoters that control the expression of collagen genes but
fluorescent proteins as tags for full-length collagen chains were not widely applied as yet [6; 7;
8; 9; 10; 11]. In one study, a DNA construct encoding a pro-α1(I) chain fused with green
fluorescent protein (GFP) was injected into the nuclei of cultured cells, and then the intracellular
translocation of the pro-α1(I)-GFP chimeras was monitored [12]. These studies, however, did
not determine whether such a fusion protein existed intracellularly as individual pro-α1(I)
chains, had the potential to co-assemble in the homotypic fashion, or was able to co-assemble in
the heterotypic fashion with endogenous pro-α1(I) and pro-α2(I) chains. In our previous studies
we genetically engineered GFP-tagged procollagen II variants in which GFP was fused at the Cterminus of the pro-α1(II) chains [13; 14; 15]. We demonstrated that the presence of GFP did not
alter the assembly of individual pro-α1(II) chains into a thermostable triple-helical structure [13].
We also demonstrated that GFP-tagged procollagen II was secreted from cells and the GFPmodified procollagen II C-propeptides were correctly processed by procollagen C-proteinase
[14; 15].
Here, we investigated the utility of a system in which individual chains of recombinant
procollagen VII that were tagged with either GFP or with monomeric red fluorescent protein
(RFP) were co-expressed in the same cells. The rationale for creating such a system was to
express heterogeneous mutant procollagen VII molecules consisting of wild type α chains and
chains that harbor a single amino acid substitution in a way similar to the expression pattern seen
in patients with dystrophic epidermolysis bullosa (DEB), a heritable blistering disease of skin
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[16; 17]. Our biochemical and microscopic assays demonstrated that the presence of two
different fluorescent proteins at the C-termini of the α chains does not prevent co-assembly of
these chains into heterogeneous triple-helical molecules and does not alter the secretion of these
GFP and RFP-tagged molecules into the extracellular space. Our study provides a basis for
employing fluorescent proteins as tags for complex collagenous proteins of the extracellular
matrix.

Materials and methods
DNA constructs encoding GFP-tagged and RFP-tagged procollagen VII variants -DNA constructs encoding mouse mini-procollagen VII α chains (mProVII) cloned into the
pCDNA3.1 vector (Invitrogen Inc.) were originally engineered, as described [18; 19]. The DNA
constructs included those encoding wild type mProVII α chains (WTmProVII) and constructs
with mutations (MTmProVII) leading to G2575R, R2622Q or G2623C substitutions [18].
Here, the construct for the WTmProVII chain was fused with a fragment of DNA that
encodes the monomeric RFP, while the constructs for the MTmProVII chains were fused with a
fragment of DNA that encodes GFP. In brief, to enable downstream cloning procedures, the
unique Not I restriction site present at the 3’ end of the original mProVII constructs was changed
to the Sal I site by employing the QuickChange Multi Site-Directed Mutagenesis Kit™
(Stratagene). The fidelity of these changed constructs was confirmed by DNA sequencing.
Subsequently, the DNA constructs for the G2575R, R2622Q, and G2623C mutants were cloned
into the Nhe I/Sal I site of the pAcGFP1-Hyg-N1 vector (Clontech Laboratories, Inc.).
The DNA construct for the WTmProVII was cloned into the Nhe I/Sal I site of the
pDsRED-monomer-Hyg-N1 vector (Clontech Laboratories, Inc.). Next, the Nhe I/Not I fragment
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of this construct that included a coding region for the mProVII-RFP chimera was cloned into the
corresponding BamH I/Not I site of an entry vector (Invitrogen, Inc.). At this stage the construct
for the WTmProVII-RFP chimera was flanked by recombination sequences attL1 and attL2.
Finally, the DNA construct was cloned into the destination vector pLenti6/V5-Dest (Invitrogen
Inc.) that includes cytomegalovirus promoter, blasticidin resistance gene, and recombination
sequences attR1 and attR2. This cloning was achieved by employing lambda phage site-specific
recombination (LR Clonase™, Invitrogen, Inc.).
HEK-293 cells expressing mProVII-GFP and mProVII-RFP variants -- To express
heterogeneous WT/MTmProVII variants consisting of GFP-tagged mutant chains and RFPtagged WT chains, initially, the DNA constructs encoding GFP-tagged mutants were transfected
into HEK-293 cells, as described [18; 19]. Subsequently, transfected cells were cultured in the
presence of hygromycin added to the final concentration of 100 µg/ml. Hygromycin-resistant
clones were individually collected and observed under an inverted fluorescence microscope
(Eclipse TE 2000U; Nikon) equipped with appropriate optical filter sets. Subsequently, the
hygromycin-resistant/GFP-positive cells were expanded in cell culture conditions and analyzed
for production of MTmProVII-GFP chimeras according to described methods [18; 19].
After selecting HEK-293 cells that express MTmProVII-GFP variants, these cells were
co-transfected with the DNA construct for the WTmProVII-RFP. After transfection, these cells
were cultured in the presence of 4 µg/ml blasticidin and 100 µg/ml hygromycin to select a
subpopulation of double-transfected cells expressing both MTmProVII-GFP and WTmProVIIRFP variants. Hygromycin/blasticidin-resistant clones were individually collected and observed
under an inverted fluorescence microscope equipped with specific set of optical filters. The
GFP/RFP-positive clones were selected and analyzed by Western blot for secretion of mProVII
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chains tagged with GFP or RFP as described above. In these assays, in addition to the anti-mouse
procollagen VII polyclonal antibodies and anti-GFP monoclonal antibody (Santa Cruz
Biotechnology), the anti-RFP polyclonal antibodies (Clontech Laboratories, Inc.) were
employed. In addition to cells co-expressing the mProVII-GFP and mProVII-RFP variants, cells
expressing only one specific variant were also selected.
Immunoprecipitation assays of co-assembly of the mutant mProVII-GFP chains with
WTmProVII-RFP chains into mProVII-GFP-RFP triple-helical molecules -- To analyze
whether the MTmProVII-GFP chains co-assembled together with the WTmProVII-RFP chains to
form heterogeneous WT/MTmProVII-RFP-GFP molecules, we employed immunoprecipitation
assays. After reaching confluency, selected cells co-expressing GFP-tagged and RFP-tagged
mProVII chains were cultured in serum-free media in the presence of 40 µg/ml of L-ascorbic
acid phosphate magnesium salt, as described [18; 19]. Medium was collected every 24 h for 6
days. Each day proteins secreted to the media were precipitated with ammonium sulfate added to
the final concentration of 300 mg/ml, and then the precipitated proteins were collected by
centrifugation. Subsequently, protein pellets collected over a 6-day period were combined,
resuspended and dialyzed against Tris-HCl buffer, pH 7.4, that included 0.4 M NaCl, 25 mM
EDTA, and 0.02% NaN3. Dialyzed proteins were concentrated by ultrafiltration on an YM-100
membrane (Millipore).
To specifically detect WT/MTmProVII-RFP-GFP heterogeneous molecules protein
samples were incubated with anti-GFP antibody in the presence of 1% bovine serum albumin
(BSA; Sigma-Aldrich) and 0.05% Tween 20 for 1 h at room temperature. After that time, the
samples were incubated for 1 h at room temperature with Protein-G conjugated to magnetic
beads (New England Biolabs, Inc.). Unbound material was removed by washing the beads
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extensively with a Tris-HCl buffer, pH 7.4, supplemented with 0.1 M NaCl and 0.05% Tween
20. Pellets consisting of magnetic beads with mProVII variants bound via anti-GFP antibodies
were boiled in the protein loading buffer. Subsequently, proteins were electrophoresed in 7.5%
polyacrylamide gels followed by electroblotting to nitrocellulose membranes. Protein bands
representing WTmProVII-RFP chains were detected with anti-RFP primary antibodies and
secondary anti-rabbit IgG antibodies conjugated with horseradish peroxidase (Sigma-Aldrich).
Control samples for immunoprecipitation assays included mixtures of the homogeneous
MTmProVII-GFP and WTmProVII-RFP molecules, samples of WT/MTmProVII-RFP-GFP
heterogeneous molecules to which the anti-GFP antibody was not added, and those containing
only the anti-GFP antibody.
Fluorescence resonance energy transfer (FRET) microscopy assays of co-assembly of
the MTmProVII-GFP chains with WTmProVII-RFP chains into WT/MTmProVII-RFP-GFP
triple-helical molecules -- Co-assembly of the GFP and RFP-tagged chains was also investigated
by assessing the proximity of the fluorescent tags in HEK-293 cells by microscopic
measurements of FRET. Fixed cells were examined with the Leica TCS SPII scanning confocal
microscope equipped with a 100x 1.4 HCX PL APO CS oil immersion objective (Leica
Microsystems, Heidelberg, Germany). FRET assays employed here were based on the acceptor
photobleaching method. According to the basis of this procedure, if two fluorophores, an
acceptor (RFP) and a donor (GFP), are positioned in a close enough proximity for FRET to
occur, then photobleaching of an acceptor should yield a significant increase in fluorescence of
the donor. In our acceptor photobleaching protocol, a selected region of interest (ROI) of a cell
was bleached in the RFP channel by scanning the selected ROI 40 times using the 568 nm argon
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laser line at 100% intensity. Before and after the bleaching, GFP images were collected to assess
changes in the donor fluorescence.
To calculate the FRET efficiencies (%) in the bleached areas (EF) of cells expressing
mProVII-GFP-RFP variants, we used the formula EF = (Dpost-Dpre)x100 / Dpost, where Dpre is prebleached pixel intensity and Dpost is post-bleached pixel intensity of the analyzed ROI. For
comparison, we also performed calculations of the pseudo-FRET efficiencies (CF) in the nonbleached regions of these cells. Moreover, to detect any possible pseudo-FRET in a FRETnegative control, cells expressing only the MTmProVII-GFP were employed. In this case, FRET
should not occur, because the acceptor fluorophore, RFP, is absent. For the bleaching step, cells
were illuminated at selected sites by the 568 nm laser line at 100% of full laser power and then
the EF and CF values for the bleached and non-bleached regions, respectively, were calculated as
described above. Comparisons of efficiencies calculated for bleached regions and non-bleached
regions were performed by an unpaired, two-tailed t test. In all tests the α level was set to 0.05.
Statistical analyses were performed with GraphPad Prism version 5.0 (GraphPad Software Inc.).

Results
GFP and RFP-tagged mProVII variants – MTmProVII variants harboring the G2575R,
R2622Q or G2623C substitutions were co-expressed with WTmProVII in HEK-293 cells. To
enable monitoring the co-expression of WT and mutant mProVII chains they were tagged with
RFP and GFP, respectively (Fig. 1). Western blot assays of mProVII secreted from of
hygromycin/blasticidin-resistant cells demonstrated that these cells secreted GFP-tagged and
RFP-tagged mProVII variants (Fig. 1). Co-expression of these variants by transfected cells was
further confirmed by fluorescence microscopy (Fig. 2).
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Immunoprecipitation assays of co-assembly of the GFP-tagged and RFP-tagged
mProVII chains – Immunoprecipitation assays were employed to determine whether the RFPtagged WTmProVII chains co-assembled with the GFP-tagged MTmProVII chains into one
triple-helical molecule. Detecting the WTmProVII-RFP chains in molecules secreted from HEK293 cells and immunoprecipitated with the anti-GFP antibody strongly indicates co-assembly of
mProVII chains tagged with these fluorophores (Fig. 3). At the same time, the absence of the
RFP-positive bands in the samples consisting of the mixture of WTmProVII-RFP and
MTmProVII-GFP homotrimers indicates the absence of aggregation among these homotrimeric
molecules (Fig. 3).
FRET assays of coassembly of the GFP-tagged and RFP-tagged mProVII chains -- In
cells expressing only MTmProVII-GFP homotrimers, the mean value for the CF (-1.979 ± 9.019,
n = 55) was lower than the mean value for the EF (-1.715 ± 7.698, n = 66), but this difference
was not statistically significant (P = 0.8625). In contrast, in cells expressing both the GFP and
RFP-tagged mProVII chains, the EF value (5.833 ± 3.359) calculated from 120 bleached regions
was significantly higher than the CF value (0.2673 ± 4.620; P < 0.0001, Fig. 4).

Discussion
Fluorescent proteins have become a powerful tool for cell biology research, and at
present they are widely used to monitor the expression of proteins, to observe their intracellular
translocation, and to measure intermolecular interactions in which these proteins participate.
Although in the majority of applications fluorescent proteins do not interfere with natural
functions of tagged proteins and fluorescent protein-mediated dimerization is quite rare, the
possibility of such interference should always be considered. In particular, a fluorescent protein
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tag could not only alter the proper folding of a protein of interest, but it could also cause tagmediated atypical aggregation of this protein (for review see [2]).
Here, we studied the utility of the experimental system in which heterogeneous mProVII
variants were formed by co-assembly of α chains fused with RFP or GFP. Although the native
procollagen VII is characterized by the presence of a relatively long triple-helical domain,
studies by Chen et al. and our own research have demonstrated that mini-procollagen VII
variants consisting of a truncated triple-helical domain flanked by intact NC1 and NC2 domains
are thermostable, have correct structure, and are properly secreted from cells [18; 19; 20]. In our
current studies the rationale for tagging the individual α chains with different fluorescent
proteins was to facilitate selection of recombinant mProVII molecules that consist of WT and
mutant chains harboring single amino acid substitutions found in patients with DEB [18]. An
important aspect of such an experimental design was to determine if the presence of bulky
fluorescent proteins at the C-termini of individual mProVII chains could interfere with their
proper folding into triple-helical structure and their secretion into the extracellular space.
Although the precise mechanisms that control the assembly of individual nascent proα1(VII) chains into a triple-helical structure are not known, certain observations suggest that, in
addition to the collagenous domain, the NC1 and NC2 domains also play a critical role. In
particular, the observation that the recombinant NC1 domain alone is able to assemble into
trimers suggests that this domain may mediate recognition and assembly of individual proα1(VII) chains [21; 22]. Furthermore, the notion that the NC2 propeptide could take part in the
formation of procollagen VII molecules is supported by the observation that mutations in this
domain frequently alter the folding process, thereby leading to increased intracellular
accumulation of misfolded molecules [23].
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Here, employing immunoprecipitation and FRET assays, we demonstrated that the
presence of GFP and RFP at the C-termini of mProVII chains neither alters their folding into
homogeneous or heterogeneous triple-helical structures nor prevents their secretion into the
extracellular space. While homogeneous co-assembly of GFP-tagged pro-α1(II) chains has been
previously reported, the heterogeneous assembly of collagenous chains tagged with two different
fluorescent proteins, as observed here, has not yet been described [13; 15]. In determining the
triple-helical and heterogeneous character of the WT/MTmProVII-RFP-GFP molecules, we
excluded the possibility that the positive immunoprecipitation and FRET results obtained with
those molecules were a consequence of nonspecific aggregation of individual α chains tagged
with GFP or RFP or of the clustering of homogeneous WTmProVII-RFP and MTmProVII-GFP
triple-helical molecules. Specifically, the triple-helical character of the analyzed molecules was
evident by the fact that they were efficiently secreted from cells. This notion is supported by the
observation that mutations in procollagen VII that alter folding of nascent pro-α1(VII) chains
cause intracellular retention of unfolded or misfolded molecules [23]. The absence of aggregates
formed by the fluorescent protein-dependent clustering of homogeneous WTmProVII-RFP and
MTmProVII-GFP triple-helical molecules was evident by the lack of RFP-positive signals in
GFP-mediated immunoprecipitation in samples containing mixtures of both homotrimers.
Moreover, a relatively low FRET efficiency observed in cells expressing differentially-labeled
mProVII chains suggests that, in addition to the heterogeneous WT/MTmProVII-RFP-GFP
molecules, the homogeneous WTmProVII-RFP and MTmProVII-GFP variants were also
formed. Such a mixture of collagen molecules consisting of WT and mutant chains that assemble
into triple-helices at different combinations is similar to the formation of collagen molecules in
cells expressing mutant α chains in a heterozygous fashion [24]. These homogenous molecules,
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however, did not form tightly-packed aggregates in which GFP and RFP would be close enough
to cause FRET.
Our study demonstrates that tagging individual mProVII α chains with GFP or RFP does
not alter their folding into complex homogeneous or heterogeneous triple-helical molecules.
Moreover, the presence of bulky fluorescent proteins at the C-termini of mProVII molecules
does not interfere with their secretion into the extracellular space. Based on the results presented
here, we postulate that fluorescent proteins are suitable tags for collagenous proteins. The
presented system for tagging collagen chains offers a number of advantages for studies on the
cellular-level events in which collagenous proteins participate. In particular, the ability to coexpress differentially labeled collagen α chains enables monitoring their intracellular
localization, translocation, and analysis of various interactions in which they participate not only
in physiological but also in pathological processes occurring in connective tissues as a result of
mutations in these proteins.
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Figure Legends

Figure 1
Expression of GFP-tagged and RFP-tagged mProVII variants. Upper panel shows Western blot
analysis of mProVII variants secreted from selected clones of HEK-293 cells co-transfected with
RFP-tagged WT chains and GFP-tagged mutant chains. In each set of the upper panel, the
mProVII chains from corresponding samples were detected with anti-NC1 specific antibodies,
anti-RFP or anti-GFP-specific antibodies. Lower panel presents a schematic of mProVII variants.
Symbols: G2575R, R2622Q, and G2623C; specific amino acid substitutions in mProVII chains,
NC1, TH, and NC2; the N-terminal, triple-helical, and the C-terminal domains of mProVII
molecules, respectively. GFP and RFP are depicted as green or red cylinders, respectively.

Figure 2
Fluorescent microscopy of fixed cells co-expressing the RFP-tagged WT and the GFP-tagged
mutant mProVII chains. The upper and middle panels show intracellular distribution of GFP and
RFP, respectively, while the bottom panel is an overlap of green, red and blue (4',6-diamidino-2phenylindole-stained nuclei) channels.

Figure 3
Immunoprecipitation of mProVII variants tagged with GFP and/or RFP. mProVII molecules
were exposed to the anti-GFP antibodies. Subsequently, the mProVII-anti-GFP complexes were
precipitated and analyzed by Western blot assays for the presence of RFP. Symbols: he-G2575RGFP/WT-RFP, he-G2622Q-GFP/WT-RFP, and he-G2623C-GFP/WT-RFP; heterogeneous
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mProVII molecules consisting of RFP-tagged WT chains and GFP-tagged mutant chains, hoG2623C-GFP & ho-WT-RFP; a control sample that includes a mixture of the homogeneous
G2623C mProVII mutant tagged with GFP and homogeneous WTmProVII tagged with RFP, +/indicates the presence or the absence of the anti-GFP antibodies in the analyzed samples. The
last lane contains the RFP-tagged homogeneous WTmProVII that serves as a positive marker for
immuno-detection of RFP.

Figure 4
Representative images of a cell expressing GFP-tagged and RFP-tagged heterogeneous mProVII.
The upper panels show images of a cell observed in the red channel while the bottom panels
depict the same cell seen in the green channel. Dotted-line boxes indicate an area of a cell
subjected to bleaching in the red channel. The relative increase of the green signal after
bleaching (aB) in comparison to that before bleaching (bB) indicates occurrence of FRET.
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